W
351.60
6.22 (1.80%)
| Previous Close | 345.38 |
| Open | 343.49 |
| Volume | 533,250 |
| Avg. Volume (3M) | 553,438 |
| Market Cap | 20,923,400,192 |
| Price / Earnings (TTM) | 31.93 |
| Price / Earnings (Forward) | 27.17 |
| Price / Sales | 7.04 |
| Price / Book | 10.69 |
| 52 Weeks Range | |
| Earnings Date | 29 Jul 2025 - 4 Aug 2025 |
| Profit Margin | 22.02% |
| Operating Margin (TTM) | 22.93% |
| Diluted EPS (TTM) | 11.03 |
| Quarterly Revenue Growth (YOY) | 3.90% |
| Quarterly Earnings Growth (YOY) | 18.80% |
| Total Debt/Equity (MRQ) | 78.58% |
| Current Ratio (MRQ) | 1.81 |
| Operating Cash Flow (TTM) | 758.81 M |
| Levered Free Cash Flow (TTM) | 588.83 M |
| Return on Assets (TTM) | 11.61% |
| Return on Equity (TTM) | 40.82% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Bearish | Bearish |
| Diagnostics & Research (Global) | Bearish | Bearish | |
| Stock | Waters Corporation | Bearish | Bullish |
AIStockmoo Score
0.6
| Analyst Consensus | -0.5 |
| Insider Activity | -3.0 |
| Price Volatility | 2.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 3.0 |
| Average | 0.60 |
|
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Mid Core |
| % Held by Insiders | 0.16% |
| % Held by Institutions | 98.20% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 375.00 (B of A Securities, 6.66%) | Hold |
| Median | 367.00 (4.38%) | |
| Low | 350.00 (Barclays, -0.46%) | Hold |
| Average | 364.75 (3.74%) | |
| Total | 1 Buy, 3 Hold | |
| Avg. Price @ Call | 340.12 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| B of A Securities | 26 Jun 2025 | 375.00 (6.66%) | Hold | 354.91 |
| Baird | 07 May 2025 | 374.00 (6.37%) | Buy | 345.46 |
| 22 Apr 2025 | 355.00 (0.97%) | Buy | 330.71 | |
| UBS | 07 May 2025 | 360.00 (2.39%) | Hold | 345.46 |
| Barclays | 10 Apr 2025 | 350.00 (-0.46%) | Hold | 314.66 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CARPIO ROBERT L III | - | 346.80 | -134 | -46,471 |
| Aggregate Net Quantity | -134 | |||
| Aggregate Net Value ($) | -46,471 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 346.80 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| CARPIO ROBERT L III | Officer | 24 Jun 2025 | Disposed (-) | 134 | 346.80 | 46,471 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |